MICHAEL D WEST Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL D WEST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL D WEST. MICHAEL D WEST is an Chief Executive Officer in BIOTIME INC ($BTX) and an Co-Chief Executive Officer in BIOTIME INC ($BTX) and a Director in BIOTIME INC ($BTX) and a Director in OncoCyte Corp ($OCX) and an Chief Executive Officer in AgeX Therapeutics, Inc. ($AGE).
Address: ONE INNOVATION DRIVE WORCESTER 01605 MA
Companies in which MICHAEL D WEST is an Insider
AgeX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL D WEST: Chief Executive Officer
Holdings: 33,723 shares
Latest Transaction: Jun 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lineage Cell Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL D WEST: Co-Chief Executive Officer, Chief Executive Officer, Director
Holdings: 897,696 shares
Current Value: $2,746,950
Latest Transaction: Sep 19 2018
$BTX Market Capitalization: $309.34M
$BTX Previous Close: $3.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoCyte Corp
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of MICHAEL D WEST: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 18 2016
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL D WEST
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 1.45 | 120,000 | 174,000 | 120,000 | |
| Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 25,000 | |
| Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 2.03 | 1,284 | 2,607 | 32,439 | 33.7 K to 32.4 K (-3.81 %) |
| Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 33,723 | 30.6 K to 33.7 K (+10.21 %) |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 28,125 | |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 1.69 | 1,081 | 1,827 | 30,598 | 31.7 K to 30.6 K (-3.41 %) |
| Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 31,679 | 28.6 K to 31.7 K (+10.94 %) |